SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-08
👔
KAZIA THERAPEUTICS LTD
@KZIA_InsiderForm 4 Filing: Friend John E. II Acquires (Grant) shares of $KZIA
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
KAZIA THERAPEUTICS LTD
Ticker: $KZIA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-01-08
Shares: 650,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Friend John E. II, holds the title of Chief Executive Officer at KAZIA THERAPEUTICS LTD.
On 2026-01-08, the insider transacted 650,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Friend John E. II (Chief Executive Officer) was granted $0 of $KZIA
Post-Transaction Position: 500,000 shares
SEC Accession No: 0001213900-26-076430 (CIK: 1704021)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.